SCHEMBL19617551

SCHEMBL19617551

Fc1ccc2nc(C3CCNCC3)sc2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.64
KMT2A Q03164 2/20 0.64
NPC1 O15118 5/20 0.57
RAB9A P51151 5/20 0.57
GFER P55789 3/20 0.47
AXL P30530 1/20 0.47
UBE2M P61081 3/20 0.45
DCUN1D1 Q96GG9 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
ALDH1A1 P00352 3/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
PKM P14618 1/20 0.44
ALOX12 P18054 1/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MPO P05164 1/20 0.43
GAA P10253 1/20 0.43
ROCK2 O75116 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7967354 0.88 NPC1 (0.68) MEN1KMT2ANPC1RAB9AGFER
SCHEMBL14896425 0.86 GFER (0.51) MEN1KMT2ANPC1RAB9AGFER
SCHEMBL29210745 0.82 MEN1 (0.64) MEN1KMT2ANPC1RAB9AUBE2M
SCHEMBL7956092 0.82 MEN1 (0.64) MEN1KMT2ANPC1RAB9AGFER
SCHEMBL20791625 0.82 MEN1 (0.64) MEN1KMT2ANPC1RAB9AUBE2M
SCHEMBL8314254 0.82 NPC1 (0.77) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL30886966 0.82 MEN1 (0.64) MEN1KMT2ANPC1RAB9AUBE2M
Hydrochloric Acid SCHEMBL20135246 0.81 MEN1 (0.62) MEN1KMT2ANPC1RAB9AUBE2M
SCHEMBL29264373 0.79 MEN1 (0.59) MEN1KMT2ANPC1RAB9AGFER
SCHEMBL2710382 0.78 KMT2A (1.00) MEN1KMT2ANPC1RAB9AGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3458447-B1 PIPERAZINYL METHANONE NAAA INHIBITORS UNIV CALIFORNIA (US) 2023-11-29 EP disclosed
CN-109476616-B Piperazinyl methanone NAAA inhibitors 加利福尼亚大学董事会 2023-10-13 CN disclosed
US-10556892-B2 Piperazinyl methanone NAAA inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-02-11 US disclosed
US-20190177313-A1 PIPERZINYL METHANONE NAAA INHIBITORS FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2019-06-13 US disclosed
EP-3458447-A1 PIPERAZINYL METHANONE NAAA INHIBITORS The Regents of The University of California (US) 2019-03-27 EP disclosed
WO-2017201103-A1 PIPERAZINYL METHANONE NAAA INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190177313-A1 PIPERZINYL METHANONE NAAA INHIBITORS NAAA, NAA15, NAA50 MEN1 2432/4885KMT2A 1167/4885NPC1 206/4885
US-10556892-B2 Piperazinyl methanone NAAA inhibitors NAAA, NAA50, NAA15 MEN1 2272/4885KMT2A 1224/4885NPC1 226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.